Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: the role of anti-VEGF and anti-EGFR antibodies.

Geva R, Prenen H, Topal B, Aerts R, Vannoote J, Van Cutsem E.

J Surg Oncol. 2010 Dec 15;102(8):937-45. doi: 10.1002/jso.21760. Review.

PMID:
21165996
2.

First- and second-line therapy of metastatic colorectal cancer.

Terstriep S, Grothey A.

Expert Rev Anticancer Ther. 2006 Jun;6(6):921-30. Review.

PMID:
16761936
3.

Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer.

Lee D.

Clin Colorectal Cancer. 2004 Sep;4(3):159-62. Review. No abstract available.

PMID:
15377399
4.

Molecular mechanisms and targeting of colorectal cancer.

Vanhoefer U.

Semin Oncol. 2005 Dec;32(6 Suppl 8):7-10. Review.

PMID:
16360005
5.

[Current medicinal treatment of metastasized colorectal carcinoma].

Folprecht G.

Chirurg. 2010 Jun;81(6):507-15. doi: 10.1007/s00104-010-1892-8. Review. German.

PMID:
20574792
6.

Treatment of metastatic colorectal cancer with monoclonal antibody to vascular endothelial growth factor: does the metastatic site make the difference?

Graziano F, Cascinu S.

J Clin Oncol. 2003 Sep 15;21(18):3542-3; author reply 3543. No abstract available.

PMID:
12972535
8.

Curing patients with liver metastases from colorectal cancer.

[No authors listed]

Drug Ther Bull. 2011 Apr;49(4):42-5; quiz i-ii. doi: 10.1136/dtb.2011.02.0022. Review.

PMID:
21467575
9.

Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.

Yoo PS, Lopez-Soler RI, Longo WE, Cha CH.

Clin Colorectal Cancer. 2006 Sep;6(3):202-7. Review.

PMID:
17026789
10.

Systemic therapy for metastatic colorectal cancer: current questions.

Zuckerman DS, Clark JW.

Cancer. 2008 May 1;112(9):1879-91. doi: 10.1002/cncr.23409.

11.

First-line treatment of patients with metastatic colorectal cancer: an overview of recent data on chemotherapy plus targeted agents.

Cercek A, Saltz LB.

Clin Colorectal Cancer. 2008 Dec;7 Suppl 2:S47-51. doi: 10.3816/CCC.2008.s.007. Review.

PMID:
19064406
12.

Cetuximab in the treatment of colorectal cancer.

Ciardiello F, De Vita F, Orditura M, Comunale D, Galizia G.

Future Oncol. 2005 Apr;1(2):173-81. Review.

PMID:
16555987
13.

Integrating targeted agents into therapeutic regimens for patients with resectable colorectal cancer.

Marshall JL.

Clin Colorectal Cancer. 2008 Dec;7 Suppl 2:S63-6. doi: 10.3816/CCC.2008.s.010. Review.

PMID:
19064409
15.

Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.

Rodriguez NA, Ascaso FJ.

J Clin Oncol. 2011 Jun 20;29(18):e532-3. doi: 10.1200/JCO.2011.34.6858. Epub 2011 Apr 11. No abstract available.

PMID:
21483009
16.

Challenges in everyday surgical practice: synchronous bilobar hepatic colorectal metastases--newer multimodality approach.

Lygidakis NJ, Bhagat AD, Vrachnos P, Grigorakos L.

Hepatogastroenterology. 2007 Jun;54(76):1020-4.

PMID:
17629030
17.

Targeted therapy in colorectal cancer: current status and future challenges.

Koutras AK, Starakis I, Kyriakopoulou U, Katsaounis P, Nikolakopoulos A, Kalofonos HP.

Curr Med Chem. 2011;18(11):1599-612. Review.

PMID:
21428886
18.

Monoclonal antibodies in gastrointestinal cancers.

Bronte G, Cicero G, Cusenza S, Galvano A, Musso E, Rizzo S, Sortino G, Roselli M, Bazan V, Fiorentino E, Russo A.

Expert Opin Biol Ther. 2013 Jun;13(6):889-900. doi: 10.1517/14712598.2013.774367. Epub 2013 Feb 27. Review.

PMID:
23441760
19.

Current issues in the targeted therapy of advanced colorectal cancer.

Knijn N, Tol J, Punt CJ.

Discov Med. 2010 Apr;9(47):328-36. Review.

20.

[Long-term beneficial effects of cetuximab in a woman with metastasised rectal carcinoma without expression of the epidermal growth factor receptor].

Kroep JR, Gelderblom H, Collen AF, Nortier JW.

Ned Tijdschr Geneeskd. 2006 Nov 18;150(46):2555-9. Dutch.

PMID:
17152334

Supplemental Content

Support Center